RP-1 Fires Up Tumors but Fails to Get FDA Approval

Annals of Surgical Oncology 2026 Open access

Read full text

Authors: Tina J. Hieken, Charlotte Eielson Ariyan

DOI: 10.1245/s10434-025-18984-1

Cited by: 0

References: 14

Fields of Study & Subjects

PARP inhibition in cancer therapy Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations

References 14